67092-20-0

Basic information

• Product Name: 2,8-Dichloro-quinazoline
• Synonyms: 2,8-Dichloro-quinazoline
• CAS NO: 67092-20-0
• Molecular Formula: C₈H₄Cl₂N₂
• Molecular Weight: 199.04
• Mol File: 67092-20-0.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 210.976°C at 760 mmHg
• Flash Point: 101.202°C
• Appearance: /
• Density: 1.487g/cm³
• Vapor Pressure: 0.271mmHg at 25°C
• Refractive Index: 1.671
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2,8-Dichloro-quinazoline(CAS DataBase Reference)
• NIST Chemistry Reference: 2,8-Dichloro-quinazoline(67092-20-0)
• EPA Substance Registry System: 2,8-Dichloro-quinazoline(67092-20-0)

Safety Data

• Hazardous Substances Data: 67092-20-0(Hazardous Substances Data)

Usage

General Description

2,8-Dichloro-quinazoline is a chemical compound with the molecular formula C8H5Cl2N3. It is classified as a quinazoline derivative, which is a heterocyclic compound containing a benzene ring fused to a pyrimidine ring. 2,8-Dichloro-quinazoline is used in the pharmaceutical industry as a building block for the synthesis of various drugs and biologically active compounds. It is also used in research and development as a starting material for the synthesis of new potential drug candidates. Additionally, 2,8-Dichloro-quinazoline has been studied for its potential antimicrobial and anticancer properties, making it a subject of interest in medicinal chemistry research.

InChI:InChI=1/C8H4Cl2N2/c9-6-3-1-2-5-4-11-8(10)12-7(5)6/h1-4H

Upstream product

• 1107694-84-7 2,8-dichloroquinazoline-4-amine 
• 22233-52-9 3-chloro-2-nitrobenzaldehyde 
• 397322-82-6 2-amino-3-chlorophenylformaldehyde 
• 60610-15-3 8-Chlor-2-oxo-1,2-dihydrochinazolin 

Downstream Products

• 1169787-68-1 N-(3-(8-chloroquinazolin-2-ylamino)phenyl)acetamide 

Relevant articles and documents

Substituted piperazine compounds, application method and applications thereof

The invention discloses substituted piperazine compounds, an application method and applications thereof. Specifically, the invention relates to piperazine compounds and pharmaceutical compositions thereof for inhibiting reuptake of 5-hydroxytryptamine and/or stimulation of 5-HT1A acceptor. The invention also relates to a preparation method of the compounds and pharmaceutical compositions thereof, and an application of the compounds and pharmaceutical compositions thereof in the treatment of central nervous system dysfunction.

NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS

Unsaturated nitrogen heterocyclic compounds of formula (I): (I), as defined in the specification, compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, Huntington's Disease, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

A simple new method for preparation of 2 substituted quinazoline derivatives

-